Answers are grounded in this paper and cite their sources.
Addiction is a chronic, relapsing brain disorder characterized by compulsive substance seeking, impaired control over drug use, and persistent neuroadaptive alterations. The addiction cycle model describes the addiction process as three interrelated stages: the binge/intoxication stage, the withdrawal/negative affect stage, and the preoccupation/anticipation (craving) stage. These stages involve dysfunction within reward circuits, prefrontal–limbic networks, and the extended amygdala system. Although substantial progress has been made in elucidating the neurobiological mechanisms of addiction, translation of these findings into personalized clinical strategies remains challenging because of disease heterogeneity and phase-dependent neural adaptations. From a precision translational medicine perspective, this review integrates the addiction cycle model with recent advances in addiction neurobiology and neuroimaging research. The review highlights multiscale neuroadaptations underlying addiction progression, including molecular and epigenetic regulation, cellular alterations, synaptic remodeling, and circuit-level reorganization. Unlike dopamine-centric models, this review emphasizes that dynamic interactions among reward processing, stress systems, and cognitive control networks contribute to the transition from voluntary substance use to compulsive behavior. By integrating the addiction cycle model with advanced neuroimaging approaches, this review further discusses stage-specific structural and functional alterations and their potential as clinically relevant neurobiological biomarkers. Emerging approaches, including multimodal neuroimaging, artificial intelligence-based analysis, and computational neuroscience, are discussed for their potential applications in biological subtyping, relapse prediction, treatment-response assessment, and personalized intervention. Finally, major challenges in precision addiction medicine are highlighted, including substance-specific heterogeneity, limited biomarker reproducibility, and insufficient longitudinal and multicenter validation. Addiction is a multi-level dynamic process of neural adaptation from molecular level adaptations to remodeling of neural circuits and from reward-driven behaviors to negative emotions and vulnerability to relapse. Together, these processes may contribute to the persistence of addiction and vulnerability to relapse. In the future, integrating multiscale biological information including molecular signatures, cellular adaptations, neural circuit remodeling, multimodal neuroimaging and AI-driven computational models may enable prediction of addiction progression and identification of clearly biologically defined subtypes of addiction. By integrating multiscale biological mechanisms, neuroimaging biomarkers and computational predictive models, addiction research will move from a symptom-based diagnosis to biologically based precision classification and personalized interventions.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: